Takeda-led COVID-19 plasma treatment enters clinical trial with first patient
Japan's Takeda Pharmaceutical Co said on Friday an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for COVID-19…
